Navigation Links
Vasopressin Found To Boost Survival In Sudden Cardiac arrest

Each year, more than 600,000 people die of sudden cardiac arrest in North America and Europe, usually because of // a heart attack or a heart rhythm disturbance.
When medical personnel arrive, nearly 70 percent of victims have ventricular fibrillation, in which the heart's main pumping chambers flutter wildly and pump little blood. Less than 20 percent of these patients survive to go home.

About 30 percent of victims, usually patients who have been down longer, have asystole, and nearly all die.
For a century, cardiac arrest victims have been given epinephrine, a synthetic adrenaline that constricts blood vessels and boosts blood pressure. It is often administered when shocking the heart with a defibrillator fails to revive the patient.

Vasopressin, a synthetic hormone that narrows blood vessels, has been around for decades. A few years ago, the International Liaison Committee on Resuscitation revised its guidelines to add vasopressin as an alternative first drug. That was partly because epinephrine sometimes increases irregular rhythms and decreases oxygen supply to the brain after resuscitation.

Researchers studied 1,186 cardiac arrest patients treated in 33 communities in Austria, Germany and Switzerland from 1999 to 2002.
After ambulance crews tried defibrillation, half the patients not resuscitated then got one or more injections of vasopressin and the other half got epinephrine.Using vasopressin improved the chances of reaching a hospital alive by about 40 percent, and tripled the chances of going home from the hospital, in patients with the most deadly type of cardiac arrest, asystole, where all heart activity has stopped. Still, only 5 percent who got vasopressin made it home.

Researchers say their findings should soon change international guidelines for treating people in cardiac arrest outside a hospital .
However these advances should be translated into a new standard of care as soon as possi ble.
Researchers say they want to go one step further and inject both vasopressin and epinephrine, because that showed the most benefit and saved eight crucial minutes.

"If truly confirmed by another study it would be a major advancement in the treatment of asystole," say specialists.
'"/>




Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... After many months of preparation, the providers ... Phoenix, Arcadia Allergy & Asthma. This new allergy and asthma clinic is conveniently located ... one stop destination for any immunological and respiratory medical care needs. , In the ...
(Date:1/14/2019)... ... January 15, 2019 , ... Early bird pricing for Medical Device ... management is just plain hard, complicated, conflicted, confusing. And it is getting even more ... are not intended as “major”, the new standard adds new definitions, changes the clause ...
(Date:1/14/2019)... ... ... Reviewed & Approved Living Well Providers of 2019. , Acupuncture, Dr. Wai ... - Maplewood , Dr. Joanna Jodar - Somerset , Dr. Barbara Knoll - ... Pleasant , Dr. Robert J. Reinhardt - Pequannock , Dr. Sylvester Rich - ...
(Date:1/13/2019)... (PRWEB) , ... January 12, 2019 , ... ... Professionals Committee (YPC) in conjunction with Temple University hosted a continuing education (CEU) ... and Mentees. The event aimed to create a series of talks to ...
(Date:1/11/2019)... MINNEAPOLIS (PRWEB) , ... January 11, 2019 , ... ... announced the three finalist teams in its “Next Generation Captive Insurance Solutions for ... by Strategic Risk Solutions. , The three finalist teams are: , ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... ... January 10, 2019 , ... Pelican BioThermal , ... rapidly expand under the leadership of Dominic Hyde, vice president of Credo™ on ... temperature controlled shipper rental program allowing organizations to choose the shipper application that ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... ... as a kind of partnership. The implicit terms of this partnership hold that ... and administer the most effective treatment to restore the patient to improved health. ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... announced today that Philips, the leading international health technology company, has taken a ... Additional investors include StartUp Health and NueCura Partners. , Babyscripts has spent the ...
Breaking Medicine Technology: